Last reviewed · How we verify
levo-bupicaine
levo-bupicaine is a Small molecule drug developed by Basque Health Service. It is currently FDA-approved.
Levo-bupicaine is a small molecule local anesthetic. It has been studied in clinical trials for its use as a local anesthetic, particularly in the context of surgical procedures such as modified radical mastectomy with expander.
At a glance
| Generic name | levo-bupicaine |
|---|---|
| Sponsor | Basque Health Service |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Infusion of a Local Anaesthetic in the Surgical After Modified Radical Mastectomy With Expander (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- levo-bupicaine CI brief — competitive landscape report
- levo-bupicaine updates RSS · CI watch RSS
- Basque Health Service portfolio CI
Frequently asked questions about levo-bupicaine
What is levo-bupicaine?
Who makes levo-bupicaine?
What development phase is levo-bupicaine in?
Related
- Manufacturer: Basque Health Service — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing